Plant stomatal opening promoter
A novel compound with high stomatal opening-promoting activity, synthesized via a simple route, addresses the production challenges of existing compounds, enhancing plant CO2 absorption and growth efficiency.
Patent Information
- Application Number
- JP2025078898
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-09
- Publication Date
- 2026-11-19
AI Technical Summary
Known compounds with stomatal opening-promoting activity have complex and costly synthetic routes, leading to high production costs and instability, making them unsuitable for mass production.
Development of a novel compound with high stomatal opening-promoting activity that can be synthesized through a simple route, using a compound represented by Formula (I) and its agriculturally acceptable salts or solvates, which can be produced at a lower cost.
The novel compound exhibits high stomatal opening-promoting activity and can be produced efficiently, promoting plant CO2 absorption and growth, thus offering a cost-effective solution for plant promotion.
Smart Images

Figure 2026182567000001_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The present invention relates to a plant stomatal opening promoter.
BACKGROUND ART
[0002] Towards the achievement of carbon neutrality, the development of radical CO2 capture technologies is being advanced. For example, a technique using a compound having an activity of improving the opening degree of stomata, which are the CO2 intake ports in plants (hereinafter also referred to as "stomatal opening promoting activity"), can be mentioned. It is expected that by applying a compound having stomatal opening promoting activity to a plant, the CO2 absorption of the plant can be promoted, and as a result, the growth of the plant can be promoted.
[0003] Patent Document 1 describes a plant stomatal opening regulator or plant growth promoter containing, as an active ingredient, at least one selected from the group consisting of a compound represented by General Formula (1), a compound represented by General Formula (2), salts of these compounds, and solvates of these compounds or salts thereof, or at least one selected from the group consisting of a compound represented by General Formula (3), a salt of this compound, and a solvate of this compound or a salt thereof.
RELATED ART DOCUMENTS
PATENT DOCUMENTS
[0004]
PATENT DOCUMENT 1
SUMMARY OF THE INVENTION
PROBLEMS TO BE SOLVED BY THE INVENTION
[0005] As mentioned above, compounds with specific structures are known to possess stomatal opening-promoting activity. However, known compounds with stomatal opening-promoting activity often require long and complex synthetic routes for production. Furthermore, known compounds with stomatal opening-promoting activity are often unstable. For these reasons, known compounds with stomatal opening-promoting activity have the drawback of being expensive and unsuitable for mass production.
[0006] Therefore, the present invention aims to provide a compound that has high stomatal opening-promoting activity and can be produced by a simple synthetic route. [Means for solving the problem]
[0007] The inventors investigated various means to solve the above-mentioned problems. Based on the structures of known compounds having stomatal opening-promoting activity, the inventors synthesized a group of compounds having similar structures and discovered a novel compound having stomatal opening-promoting activity. Furthermore, the inventors found that this novel compound has high stomatal opening-promoting activity and can be produced by a simple synthesis route. Based on the above findings, the inventors completed the present invention.
[0008] In other words, the present invention encompasses the following aspects and embodiments. (Embodiment 1) Formula (I): [ka] [In the formula, R 1 is H, halogen, trimethylsilyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring, and if the carbocyclic or heterocyclic ring is substituted, the substituent is one to three monovalent groups selected from the group consisting of hydroxyl, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted alkoxy, and substituted or unsubstituted amino. R 2 is H, a substituted or unsubstituted alkyl, or a substituted or unsubstituted acyl, R3 is absent, substituted or unsubstituted alkyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic ring or heterocyclic ring, L is a single bond, ethane-1,2-diyl, ethene-1,2-diyl, or ethyne-1,2-diyl, X 1 , X 2 , and X 3 are each independently CH, N, O or S, provided that when X 1 , X 2 , or X 3 is O or S, R 3 is absent.] a plant stomatal opening promoter comprising, as an active ingredient, the compound represented by or an agriculturally acceptable salt thereof, or an agriculturally acceptable solvate thereof. (Embodiment 2) R 1 is H, halogen, trimethylsilyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic ring or heterocyclic ring, and when the carbocyclic ring or heterocyclic ring is substituted, the substituent is 1 to 3 monovalent groups selected from the group consisting of hydroxyl, halogen, substituted or unsubstituted C1 to C8 alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted C1 to C8 alkoxy, and substituted or unsubstituted amino, R 2 is H, substituted or unsubstituted C1 to C8 alkyl, or substituted or unsubstituted C1 to C8 acyl, R 3 is absent, substituted or unsubstituted C1 to C8 alkyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic ring or heterocyclic ring, the plant stomatal opening promoter according to Embodiment 1. (Embodiment 3) The plant stomatal opening promoter according to Embodiment 1 or 2, wherein L is a single bond or ethyne-1,2-diyl. (Embodiment 4) R 1 is phenyl, R 2 is H, R 3 is propan-2-yl, L is ethyne-1,2-diyl, X 1 and X 2 However, N is, X 3 A plant stomatal opening promoter according to any one of embodiments 1 to 3, wherein CH is present. (Embodiment 5) The following formula: [ka] A compound represented by or a salt thereof, or a solvate thereof. [Effects of the Invention]
[0009] The present invention makes it possible to provide a compound that has high stomatal opening-promoting activity and can be produced through a simple synthetic route. [Brief explanation of the drawing]
[0010] [Figure 1] The results of the stomatal opening-promoting activity measurement test are shown. In the figure, the horizontal axis represents the test compound, and the vertical axis represents the stomatal opening (μm). The bars and error lines for each test compound show the mean and standard error of the stomatal opening. [Figure 2] The dose-response results for the stomatal opening-promoting activity of compound 1 are shown. In the figure, the horizontal axis represents the concentration of compound 1 (μM), and the vertical axis represents the stomatal opening (μm). The bars and error lines for each test compound show the mean and standard error of the stomatal opening. [Modes for carrying out the invention]
[0011] Preferred embodiments of the present invention will be described in detail below.
[0012] <1. Plant stomatal opening promoter> One aspect of the present invention is formula (I): [ka] This invention relates to a plant stomatal opening promoter containing a compound represented by , an agriculturally acceptable salt thereof, or an agriculturally acceptable solvate thereof as an active ingredient. The active ingredient compound contained in the plant stomatal opening promoter of this embodiment has high stomatal opening promoting activity and can be produced by a simple synthesis route.
[0013] In equation (I), R 1 R is H, a halogen, a trimethylsilyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring. 1 It is preferably a halogen selected from H, fluorine, chlorine, bromine, and iodine, trimethylsilyl, substituted or unsubstituted phenyl, or substituted or unsubstituted thiophene-3-yl, and more preferably phenyl.
[0014] R 1 If the carbon ring or heterocycle is substituted, the substituents are 1 to 3 monovalent groups selected from the group consisting of hydroxyl, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted alkoxy, and substituted or unsubstituted amino. Preferably, the substituents are 1 to 3 monovalent groups selected from the group consisting of halogen selected from hydroxyl, fluorine, chlorine, bromine, and iodine, substituted or unsubstituted C1 to C8 alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted C1 to C8 alkoxy, and substituted or unsubstituted amino, and more preferably 1 to 3, particularly 1, monovalent group selected from the group consisting of halogen selected from hydroxyl, fluorine, chlorine, bromine, and iodine, methyl, phenyl, methoxy, ethoxy, and amino.
[0015] In equation (I), R 2 R is H, a substituted or unsubstituted alkyl, or a substituted or unsubstituted acyl. 2 The element is preferably H, a substituted or unsubstituted C1 to C8 alkyl, or a substituted or unsubstituted C1 to C8 acyl, more preferably H, methyl, ethyl, 2-(4-methylphenyl)acetyl, or 2-(4-chlorophenyl)acetyl, and even more preferably H.
[0016] In equation (I), R 3 R is an unsubstituted, substituted, or unsubstituted alkyl group, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring. 3 It is preferably an unsubstituted, substituted, or unsubstituted C1 to C8 alkyl group, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring, more preferably unsubstituted, propan-2-yl, propan-1-yl, or hexane-1-yl, and even more preferably propan-2-yl.
[0017] In formula (I), L is a single bond, ethane-1,2-diyl, ethene-1,2-diyl, or ethyne-1,2-diyl. L is preferably a single bond or ethyne-1,2-diyl, and more preferably ethyne-1,2-diyl.
[0018] In equation (I), X 1 , X 2 , and X 3 These are, independently of each other, CH, N, O, or S. 1 , X 2 , and X 3 Preferably, each element is independently CH, N, or O, and each element is independently CH, N, or X 1 However, it is CH or N, and X 2 However, it is N or O, and X 3 However, it is more preferable that it be CH or N, X 1 and X 2 However, N is and X3 However, it is even more preferable that it be CH. However, X 1 , X 2 , or X 3 When is O or S, R 3 He is absent.
[0019] In formula (I), if the group is substituted, the substituents are, unless otherwise defined, halogens (fluorine, chlorine, bromine, or iodine), cyano, nitro, hydroxyl, substituted or unsubstituted C1-C5 alkyl, substituted or unsubstituted C2-C5 alkenyl, substituted or unsubstituted C2-C5 alkynyl, substituted or unsubstituted C3-C6 cycloalkyl, substituted or unsubstituted C4-C6 cycloalkenyl, substituted or unsubstituted C4-C6 cycloalkynyl, substituted or unsubstituted 3- to 6-membered heterocycloalkyl, substituted or unsubstituted C3-C6 cycloalkyl-C1-C5 alkyl, substituted or unsubstituted 3- to 6-membered heterocycloalkyl-C1-C5 alkyl, substituted or unsubstituted C6-C 15 Aryl, substituted, or unsubstituted C6-C 15 Aryl-C1~C5 alkyl, substituted or unsubstituted 5~15 member heteroaryl, substituted or unsubstituted 5~15 member heteroaryl-C1~C5 alkyl, substituted or unsubstituted C1~C6 alkoxy, substituted or unsubstituted C3~C6 cycloalkoxy, substituted or unsubstituted 3~6 member heterocycloalkoxy, substituted or unsubstituted C6~C 15 Aryloxy, substituted or unsubstituted C6-C 15 Aryl-C1~C5 alkyloxy, substituted or unsubstituted 5~15 member heteroaryloxy, substituted or unsubstituted 5~15 member heteroaryl-C1~C5 alkyloxy, substituted or unsubstituted C1~C6 alkoxycarbonyl, substituted or unsubstituted C3~C6 cycloalkoxycarbonyl, substituted or unsubstituted C1~C 20 Acyl, substituted, or unsubstituted C1-C 20Preferably, the monovalent group is at least one monovalent group selected from the group consisting of acyloxy, substituted or unsubstituted C1-C9 alkylsulfanyl, and substituted or unsubstituted amino. If the monovalent group is substituted, the substituent can be further selected from the monovalent group.
[0020] Preferably, the compound represented by formula (I) is R 1 However, the substituent is H, halogen, trimethylsilyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring, and if the carbocyclic or heterocyclic ring is substituted, the substituent is one to three monovalent groups selected from the group consisting of hydroxyl, halogen, substituted or unsubstituted C1 to C8 alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted C1 to C8 alkoxy, and substituted or unsubstituted amino. R 2 is H, a substituted or unsubstituted C1 to C8 alkyl, or a substituted or unsubstituted C1 to C8 acyl, R 3 This is a C1 to C8 alkyl group that is absent, substituted or unsubstituted, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring. L is a single bond, ethane-1,2-diyl, ethene-1,2-diyl, or ethyne-1,2-diyl. X 1 , X 2 , and X 3 These are, independently of each other, CH, N, O, or S. However, X 1 , X 2 , or X 3 When is O or S, R 3 He is absent.
[0021] More preferably, the compound represented by formula (I) is R 1However, the substituent is a halogen selected from H, fluorine, chlorine, bromine, and iodine, trimethylsilyl, substituted or unsubstituted phenyl, or substituted or unsubstituted thiophene-3-yl, and if the phenyl or thiophene-3-yl is substituted, the substituent is one to three monovalent groups selected from the group consisting of hydroxyl, halogen selected from fluorine, chlorine, bromine, and iodine, methyl, phenyl, methoxy, ethoxy, and amino. R 2 is H, methyl, ethyl, 2-(4-methylphenyl)acetyl, or 2-(4-chlorophenyl)acetyl, R 3 It is absent, propan-2-yl, propan-1-yl, or hexane-1-yl. L is a single bond or etyn-1,2-diyl. X 1 , X 2 , and X 3 These are, independently of each other, CH, N, or X 1 However, it is CH or N, and X 2 However, it is N or O, However, X 1 , X 2 , or X 3 When is O or S, R 3 He is absent.
[0022] More preferably, the compound represented by formula (I) is R 1 However, it is phenyl, R 2 However, H is, R 3 However, it is propane-2-yl, L is etyn-1,2-diyl, X 1 and X 2 However, N is, X 3 However, it is CH.
[0023] A particularly preferred compound represented by formula (I) is a compound represented by the following formula or a salt thereof, or a solvate thereof, and in particular compound 1 or a salt thereof, or a solvate thereof. [ka] TIFF2026182567000006.tif207168
[0024] If the active ingredient compound contained in the plant stomatal opening promoter of this embodiment is one of the compounds exemplified above, the plant stomatal opening promoter of this embodiment can have high stomatal opening promoting activity. Furthermore, since the compounds exemplified above can be produced through a simple synthesis route, the plant stomatal opening promoter of this embodiment can be manufactured at a low cost.
[0025] A compound represented by formula (I) in one aspect of the present invention includes not only the compound itself but also salts thereof. Preferred salts of the compound include, but are not limited to, salts with cations such as sodium ions, potassium ions, calcium ions, magnesium ions, or substituted or unsubstituted ammonium ions; or salts with inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, carbonic acid, or phosphoric acid; or salts with organic acid anions such as formic acid, acetic acid, maleic acid, fumaric acid, benzoic acid, ascorbic acid, succinic acid, bismethylenesalicylic acid, methanesulfonic acid, ethanedisulfonic acid, propionic acid, tartaric acid, salicylic acid, citric acid, gluconic acid, aspartic acid, stearic acid, palmitic acid, itaconic acid, glycolic acid, p-aminobenzoic acid, glutamic acid, benzenesulfonic acid, cyclohexylsulfamic acid, methanesulfonic acid, ethanesulfonic acid, isethionic acid, p-toluenesulfonic acid, or naphthalenesulfonic acid. Even when the compound represented by formula (I) is in the form of the salt described above, the plant stomatal opening promoter of this embodiment containing the compound as an active ingredient can exhibit high stomatal opening promoting activity.
[0026] The compound represented by formula (I) in one aspect of the present invention includes not only the compound itself but also solvates of the compound or a salt thereof. While not limited to, solvents capable of forming a solvate with the compound or its salt include, for example, lower alcohols (e.g., alcohols having 1 to 6 carbon atoms, such as methanol, ethanol, or 2-propanol (isopropyl alcohol)), higher alcohols (e.g., alcohols having 7 or more carbon atoms, such as 1-heptanol or 1-octanol), organic solvents such as dimethyl sulfoxide (DMSO), acetic acid, ethanolamine, or ethyl acetate, or water. Even when the compound represented by formula (I) or a salt thereof is in the form of a solvate with the aforementioned solvent, the plant stomatal opening promoter of this aspect containing the compound as an active ingredient can exhibit high stomatal opening promoting activity.
[0027] A compound represented by formula (I) in one aspect of the present invention includes not only the compound itself but also its protected or deprotected forms. In this specification, "protected form" means a form in which a protecting group is introduced to one or more functional groups (e.g., a hydroxyl group, a carboxylic acid group, or an amino group), and "deprotected form" means a form in which the protecting group introduced to one or more functional groups (e.g., a hydroxyl group, a carboxylic acid group, or an amino group) is removed. In this specification, the protected form of the compound represented by each formula may be described as a protected derivative of the compound represented by each formula, and the deprotected form of the compound represented by each formula may be described as a deprotected derivative of the compound represented by each formula. In this specification, "protecting group" means a group introduced to a specific functional group to prevent the progress of an undesirable reaction, which is quantitatively removed under specific reaction conditions and is substantially stable, i.e., reaction-inactive, under other reaction conditions. The protecting groups that can form the protected form of the compound are not limited to, but for example, in the case of a hydroxyl group protecting group, silyl (e.g., trimethylsilyl (TMS), t-butyldimethylsilyl (TBS), triisopropylsilyl (TIPS), or tert-butyldiphenylsilyl (TBDPS)) or alkoxy (e.g., tert-butyloxy (tBu), methoxymethoxy (MOM), or methoxy (Me)) are preferred; in the case of a carboxylic acid group protecting group, alkyl ester (e.g., methyl, ethyl, or isopropyl ester), arylalkyl ester (e.g., benzyl ester), or amide (e.g., amide with oxazolidinones) are preferred; and in the case of an amino group protecting group, t-butoxycarbonyl (Boc), benzyloxycarbonyl (Cbz), 2-bromobenzyloxycarbonyl (BrZ), or 9-fluorenylmethoxycarbonyl (Fmoc) are preferred. Protection and deprotection with the protecting groups can be carried out as appropriate by those skilled in the art based on known reaction conditions. Even when the compound represented by formula (I) is protected by the aforementioned protecting group, it may still exhibit stomatal opening-promoting activity.
[0028] If a compound represented by formula (I) in one aspect of the present invention has one or more tautomers, the compound also includes the individual tautomer forms of the compound.
[0029] Furthermore, if a compound represented by formula (I) in one aspect of the present invention has one or more stereocenters (chiral centers), the compound also includes individual enantiomers and diastereomers of the compound, as well as mixtures thereof such as racemates.
[0030] Having the above-mentioned features, the plant stomatal opening promoter of this embodiment, which contains the compound represented by formula (I) of one embodiment of the present invention as an active ingredient, can exhibit high stomatal opening promoting activity.
[0031] In each embodiment of the present invention, the stomatal opening-promoting activity of the compound represented by formula (I) can be evaluated, for example, by the following test: A test plant (e.g., Commelina communis) is grown, and after dark treatment, the underside of a fully developed leaf is wound. The epidermis near the wound is peeled off with tweezers to obtain a small piece. A test solution containing the test compound is dispensed into the wells of a 96-well plate, and the epidermal piece is immersed therein. It is left to stand in a dark room for a predetermined time (e.g., 3 hours). After that, the short diameter of the stomata of each epidermal piece (hereinafter referred to as "stomatal opening") is measured under observation with an inverted microscope (e.g., 600x magnification). When evaluating the stomatal opening-promoting activity of the compound represented by formula (I) in the above test, it can usually exhibit stomatal opening-promoting activity at a concentration of 0.1 μM or higher.
[0032] The plant stomatal opening promoter of this embodiment may optionally contain, in addition to the compound represented by formula (I) which is the active ingredient, one or more further active ingredients and / or one or more agriculturally acceptable ingredients. Therefore, another embodiment of the present invention relates to an agricultural chemical composition comprising the compound represented by formula (I) or an agriculturally acceptable salt thereof, or an agriculturally acceptable solvate thereof, and one or more agriculturally acceptable ingredients. In the agricultural chemical composition of this embodiment, one or more agriculturally acceptable ingredients may include one or more agriculturally acceptable carriers (e.g., solvents) and auxiliary agents (e.g., inert auxiliary agents, surfactants (e.g., dispersants, protective colloids, emulsifiers and wetting agents), organic or inorganic thickeners, fungicides, antifreezes, defoamers, or colorants).
[0033] The plant stomatal opening promoter and agricultural chemical composition according to this embodiment can be used in the dosage forms and application methods of pesticides commonly used in the art. Suitable dosage forms include, for example, emulsions, wettable powders, liquids, water-soluble powders, powders, pastes, and granules. Suitable application methods include, for example, spraying, dusting, misting, dipping, and coating.
[0034] The plant stomatal opening promoter and agricultural chemical composition of this embodiment can be applied to a variety of plants, including angiosperms and gymnosperms. While not limited to these, the plants to which the plant stomatal opening promoter and agricultural chemical composition of this embodiment can be applied include not only model plants such as Brassicaceae plants like Arabidopsis thaliana and Brassica napus, and Commelinaceae plants like Commelina communis, but also crop plants such as grasses like rice, maize, wheat, and barley, legumes like soybeans, vitaceae plants like grapes, nightshade plants like petunias and tomatoes, and roseaceae plants like peaches and apples.
[0035] The compound represented by formula (I), which is the active ingredient of the plant stomatal opening promoter of this embodiment, has high stomatal opening promoting activity. Therefore, by applying the plant stomatal opening promoter of this embodiment to a plant, stomatal opening of the plant can be promoted, CO2 absorption of the plant can be promoted, and as a result, the growth of the plant can be promoted. Accordingly, another embodiment of the present invention relates to a plant CO2 absorption promoter and / or plant growth promoter comprising the compound represented by formula (I) or an agriculturally acceptable salt thereof, or an agriculturally acceptable solvate thereof, as an active ingredient. Yet another embodiment of the present invention relates to a method for promoting stomatal opening of a plant, a method for promoting CO2 absorption of the plant, and / or a method for promoting the growth of the plant, comprising applying the compound represented by formula (I), or the plant stomatal opening promoter, plant CO2 absorption promoter, plant growth promoter, or agricultural chemical composition of this embodiment to a plant or the environment in which the plant lives. By applying the plant stomatal opening promoter, plant CO2 absorption promoter, plant growth promoter, and / or agricultural chemical composition of this embodiment to a plant, or by carrying out the method of this embodiment, it is possible to promote stomatal opening of the plant, promote CO2 absorption of the plant, and as a result promote the growth of the plant.
[0036] <2. New compounds> The compound represented by formula (I), which is the active ingredient of a plant stomatal opening promoter in one aspect of the present invention, includes novel compounds. Therefore, another aspect of the present invention includes the following novel compound: [ka] This invention relates to a compound represented by , a salt thereof, or a solvate thereof. When the compound in this embodiment is the aforementioned compound, the compound can exhibit particularly high stomatal opening promoting activity.
[0037] <3. Method for producing the compound> Another aspect of the present invention relates to a compound represented by formula (I), which is an active ingredient of a plant stomatal opening promoter according to one aspect of the present invention, and a method for producing a novel compound according to another aspect of the present invention. The method of this aspect is Formula (XI):
Chemical Formula
Chemical Formula
[0038] In formulas (XI) and (XII), and the compounds R 3 -Hal and R 1 -L-H, R 1 , R 2 , R 3 , L, X 1 , X 2 , and X 3 have the same meanings as defined above.
[0039] In formulas (XI) and (XII), and the compound R 3 -Hal, Hal is halogen (fluorine, chlorine, bromine or iodine).
[0040] In the method of this embodiment, the compound represented by formula (XI), and the compounds R 3 -Hal and R 1 -L-H may be prepared by purchasing the preliminarily prepared compounds or the like, or may be prepared based on a known method. Further, the above two steps in the method of this embodiment can be carried out based on reaction conditions known in the art.
[0041] The compound represented by formula (XI) used as a raw material in the method of this embodiment, and the compounds R 3 -Hal and R 1-L-H can be obtained at low cost. Further, in the method of the present embodiment, by carrying out the two steps described above, the compound represented by Formula (I) and a novel compound can be obtained. Therefore, by the method of the present embodiment, the compound represented by Formula (I) and the novel compound can be produced at a lower production cost compared with known compounds having stomatal opening promoting activity.
Examples
[0042] Hereinafter, the present invention will be described in more detail with reference to Examples. However, the technical scope of the present invention is not limited to these Examples.
[0043] <I. Production of Compounds> [I-1. Synthesis of Compound 1]
Chemical Formula
[0044] The obtained compound 6 (200 mg), ethynylbenzene (107.6 mg, 1.09 mmol, 1.50 eq.), tetrahydrofuran (3.3 ml), and triethylamine (920 μl, 6.62 mmol, 10 eq.) were mixed and freeze-degassed three times. Then, under a nitrogen flow, bis(triphenylphosphine)palladium(II) dichloride (46.9 mg, 66.2 μmol, 0.10 eq.) and copper(I) iodide (12.6 mg, 66.2 μmol, 0.10 eq.) were added to this mixture and stirred overnight at 50°C. The reaction mixture was cooled to room temperature. Saturated aqueous ammonium chloride solution and chloroform were added to the reaction mixture, and the target product was extracted into the organic layer. The resulting organic layer was dried over anhydrous sodium sulfate. After filtering off the drying agent, the filtrate was concentrated under reduced pressure. The crude product obtained was purified by preparative liquid chromatography (silica gel) at medium pressure. The fraction of the target product was concentrated. The residue was purified by thin-layer chromatography. The obtained solid was dissolved in chloroform, activated carbon was added, and the mixture was stirred at room temperature for 2 hours. Subsequently, it was filtered by Celite to obtain a white solid of compound 1 (84.5 mg, yield 46%).
[0045] 1 H-NMR (500 MHz, CDCl3): δ 1.60 (d, 6H J = 7.0 Hz, 6H), 4.74 (sep, J = 7.0 Hz, 1H), 5.48 (bs, 2H), 6.71 (d, J=6.0 Hz, 1H) 7.38-7.46 (m, 3H), 7.60-7.62 (m, 2H), 7.84(d, J=6.0 Hz, 1H). 13 C-NMR (150 MHz, CDCl3): δ 22.06, 51.39, 81.35, 93.90, 96.30, 109.13, 121.88, 127.02, 128.53, 129.19, 131.72, 143.51, 143.91, 153.45. MS calculated value: 277.1448; MS measured value: 277.1452 ([M+1] + ).
[0046] [I-2. Synthesis of other compounds] Based on the synthesis of Compound 1, the following compounds were synthesized. [Chemical Formula]
[0047] <II. Biological Activity Test of Compounds> [II-1: Measurement Test of Stomatal Opening Promoting Activity] (II-1-1: Preparation of Epidermal Fragments) A part of the stem of Commelina benghalensis was inserted into a planter filled with mixed soil of vermiculite and dedicated sowing culture soil. This plant was grown for 2 to 4 weeks at the indoor window side with natural light (room temperature: 25 to 28°C). The planter was moved to a dark room and subjected to dark treatment overnight. After the dark treatment, the back side of the fully expanded leaf was wounded using a hole punch (Biopsy Punch, Kai Medical, Solingen, Germany). The epidermis near the wounded area was peeled off with tweezers to obtain small fragments.
[0048] (II-1-2: Preparation of Test Solutions) As test solutions, a stomatal aperture measurement solution (5 mM MES-BTP [pH 6.5], 50 mM KCl, 0.1 mM CaCl₂, 0.5% DMSO) and a test compound solution in which the test compound was dissolved in the above solution (final concentration: 50 μM) were prepared. The control test solution was prepared using DMSO instead of the test compound. As the test compounds, Compound 1 and the known stomatal opening compound PP242 shown below were used. [Chemical Formula]
[0049] (II-1-3: Procedure of Measurement Test) 100 μl / well of the test solution was dispensed into five wells of a 96-well plate, and epidermal fragments were immersed in it. The fragments were left to stand in a dark room for 3 hours. After that, the short diameter of the stomata (hereinafter referred to as "stomatal opening") of each epidermal fragment was measured under observation (600x magnification) using an inverted microscope (Olympus BX43). The above measurement test was performed using three different leaves for each test solution. Based on the measurements obtained using each test solution, the mean and standard error (SE) were calculated. Significant difference (p-value) was determined according to the Student's t-test using Excel (Microsoft). A two-tailed test was performed on homoscedastic matrices. The results are shown in Figure 1. In the figure, the horizontal axis is the test compound, and the vertical axis is the stomatal opening (μm). The bars and error lines for each test compound show the mean and standard error of the stomatal opening.
[0050] As shown in Figure 1, the addition of compound 1 significantly promoted stomatal opening. Furthermore, compound 1 showed higher stomatal opening-promoting activity compared to the known stomatal opening compound PP242.
[0051] [II-2: Dose-response of stomatal opening-promoting activity of compound 1] In Experiment II-1, the dose-response of the stomatal opening-promoting activity of compound 1 was investigated using the same procedure as above, except that the final concentration of compound 1 in the test compound solution was changed to 0.4, 10, 20, and 50 μM. The results are shown in Figure 2. In the figure, the horizontal axis represents the concentration of compound 1 (μM), and the vertical axis represents the stomatal opening (μm). The bars and error lines for each test compound show the mean and standard error of the stomatal opening.
[0052] As shown in Figure 2, compound 1 exhibited concentration-dependent stomatal opening-promoting activity. Furthermore, compound 1 showed significant stomatal opening-promoting activity even at a very low concentration of 0.4 μM.
[0053] It should be noted that the present invention is not limited to the embodiments described above, and various modifications are included. For example, the embodiments described above are described in detail to make the present invention easier to understand, and are not necessarily limited to those having all the configurations described. In addition, it is possible to add, delete, and / or replace some of the configurations in each embodiment with other configurations.
Claims
1. Equation (I): 【Chemistry 1】 [In the formula, R 1 is H, halogen, trimethylsilyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring, and if the carbocyclic or heterocyclic ring is substituted, the substituent is one to three monovalent groups selected from the group consisting of hydroxyl, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted alkoxy, and substituted or unsubstituted amino. R 2 is H, a substituted or unsubstituted alkyl, or a substituted or unsubstituted acyl, R 3 This is an unsubstituted, substituted or unsubstituted alkyl group, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring. L is a single bond, ethane-1,2-diyl, ethene-1,2-diyl, or ethyne-1,2-diyl. X 1 , X 2 , and X 3 These are, independently of each other, CH, N, O, or S. Provided that X 1 , X 2 , or X 3 is O or S, R 3 is absent.] A plant stomatal opening promoter containing a compound represented by or an agriculturally acceptable salt thereof, or an agriculturally acceptable solvate thereof, as an active ingredient.
2. R 1 However, the substituent is H, halogen, trimethylsilyl, or a substituted or unsubstituted 5-membered or 6-membered carbocyclic or heterocyclic ring, and if the carbocyclic or heterocyclic ring is substituted, the substituent is hydroxyl, halogen, substituted or unsubstituted C 1 From C 8 Alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted C 1 From C 8 It consists of 1 to 3 monovalent groups selected from the group consisting of alkoxys and substituted or unsubstituted aminos, R 2 H, substituted or unsubstituted C 1 From C 8 Alkyl, or substituted or unsubstituted C 1 From C 8 It is Asyl, R 3 C is absent, substituted, or unsubstituted. 1 From C 8 The plant stomatal opening promoter according to claim 1, wherein the alkyl group is an alkyl group, or a substituted or unsubstituted five-membered or six-membered carbocyclic or heterocyclic ring.
3. The plant stomatal opening promoter according to claim 1, wherein L is a single bond or etyn-1,2-diyl.
4. R 1 However, it is phenyl, R 2 However, H is, R 3 However, it is propane-2-yl, L is etyn-1,2-diyl, X 1 and X 2 However, N is, X 3 The plant stomatal opening promoter according to claim 1, wherein CH is present.
5. The following formula: 【Chemistry 2】 A compound represented by or a salt thereof, or a solvate thereof.
Citation Information
Patent Citations
Plant stomata opening regulator
JP2016117685A
